Effect of Repetitive Bihemispheric Anodal Transcranial Direct Current Stimulation on Motor Function of Patients With Parkinson's Disease
1 other identifier
interventional
30
1 country
1
Brief Summary
Dopaminergic medications and Deep Brain Stimulation (DBS) are the current standards interventions for Parkinson's Disease. Pharmacotherapy with dopaminergic drugs leads to partial improvement in motor functions of patients. Invasive therapies like DBS have as yet limited availability and accessibility, with risk of adverse events as well. Non invasive therapies like Transcranial Direct Current Stimulation (tDCS) are currently increasingly being probed for their therapeutic value, in view of their safety, portability and convenience of administration. Improvement in motor function immediately after a single session of tDCS has been observed. The effect of single simulation is not sustained beyond a few days. Only few studies with varied sites of stimulation have evaluated the effect of repetitive tDCS on motor function improvement in patients with Parkinson's Disease, with conflicting results. There is an unmet need to probe the utility of repetitive tDCS on motor function of patients with Parkinson's Disease. We aim to probe the effect of repetitive tDCS of dorsolateral prefrontal cortex and M1 cortex on motor function in patients with Parkinson's Disease (Hoehn and Yahr stage 2 to 4).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Feb 2026
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
CompletedFebruary 9, 2026
February 1, 2026
5 months
January 25, 2026
February 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine change in motor function score as assessed by Movement Disorder Society - Unified Parkinson's Disease Rating Scale Part - III scale 1 week after the repetitive tDCS (Minimum Score 0, Maximum Score 132, higher scores indicate more disability)
1 week
Secondary Outcomes (1)
To determine the change in Timed Up and Go test score of patients with Parkinson's Disease at 1 week after the repetitive tDCS (higher times indicate disability with increased risk of fall)
1 week
Study Arms (2)
Anodal tDCS arm (will receive true tDCS)
EXPERIMENTALWill receive true anodal tDCS stimulation
Sham tDCS arm (will receive Sham stimulation)
SHAM COMPARATORWill not receive anodal tDCS stimulation
Interventions
Anodal tDCS stimulation
Eligibility Criteria
You may qualify if:
- Patients fulfilling the Movement Disorder Society (MDS) clinical diagnostic criteria for Parkinson's disease.
- Patients with Hoehn \& Yahr stages 2-4 Parkinson's disease.
- Patients maintained on stable medical regimen for at least 1 month before entering the study.
You may not qualify if:
- Patients with other confounding neurological and psychiatric disorders.
- The presence of metal objects or stimulators in the head.
- Patients with a history of deep brain stimulation.
- Patients with history of seizures.
- Patients with skull defect due to surgery e.g. craniectomy
- Patients with scalp condition likely to obstruct application of electrodes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital
New Delhi, 110001, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ashish Kumar Duggal, DM (Neurology)
Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Department of Neurology, ABVIMS and Dr RML Hospital, New Delhi
Study Record Dates
First Submitted
January 25, 2026
First Posted
February 9, 2026
Study Start
February 1, 2026
Primary Completion
June 30, 2026
Study Completion
July 31, 2026
Last Updated
February 9, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
IPD collected throughout the trial will be available from the Principle Investigator upon reasonable request.